Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
Hosted on MSN22m
FDA Clears Spravato For Monotherapy Depression TreatmentsThe Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus ...
Johnson & Johnson has received FDA approval for Spravato nasal spray as the first and only monotherapy for adults with treatment-resistant depression.
Ruth Goldberg Jaskow still does fitness classes every day at 101. Her tips for living longer include keeping active. The RHOA ...
Trump's administration has cleared the way for arrests in schools of people suspected of being without legal status. And, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback